Lonza News 2026-01-08 Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News
Lonza News 2026-01-07 Lonza’s Synaffix and Sidewinder partner on bispecific ADCs By Investing.com - Investing.com Canada
Lonza News 2026-01-07 Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs - Yahoo Finance
Lonza News 2025-12-30 Lonza Group AG stock: Quiet rebound, cautious optimism as investors weigh biotech’s next chapter - AD HOC NEWS
Lonza News 2025-12-30 Lonza Group AG stock: quiet consolidation or coiled spring for 2026? - AD HOC NEWS
Lonza News 2025-12-30 Lonza Group AG stock: quiet consolidation or coiled spring for 2026? - AD HOC NEWS
Lonza News 2025-12-29 Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Down 28.5% in December - MarketBeat
Lonza News 2025-12-17 Will Lonza Group AG (Common Stock) (LO3A) stock gain from green policies - Weekly Gains Summary & Technical Confirmation Alerts - Bollywood Helpline
Lonza News 2025-12-15 Lonza CHI: Organic capsules for next-gen plant-based nutraceuticals - nutritioninsight.com
Lonza News 2025-12-12 Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - What's Next? - MarketBeat
Lonza News 2025-12-09 Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Mar - pharmiweb.com
Lonza News 2025-12-09 Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Market, 2025-2033: Insights by Service, Product, End-Use and Region - ResearchAndMarkets.com - The AI Journal
Lonza News 2025-12-08 Microsize Expands Global Footprint With Bold Move Into European Micronization - MyChesCo